Belogurov, Alexey Jr.
Zakharov, Konstantin
Lomakin, Yakov
Surkov, Kirill
Avtushenko, Sergey
Kruglyakov, Peter
Smirnov, Ivan
Makshakov, Gleb
Lockshin, Curtis
Gregoriadis, Gregory
Genkin, Dmitry
Gabibov, Alexander
Evdoshenko, Evgeniy
Funding for this research was provided by:
Ministry of Education and Science of the Russian Federation (RFMEFI60714X0061)
OJSC Pharmsynthez
This article is maintained by: Elsevier
Article Title: CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study
Journal Title: Neurotherapeutics
CrossRef DOI link to publisher maintained version: https://doi.org/10.1007/s13311-016-0448-0
Content Type: article
Copyright: Copyright © 2016 The Author(s). Published by Elsevier B.V. All rights reserved.